Treprostinil (marketed under the trade names Remodulin for infusion and Tyvaso for inhalation) is a vasodilator that is used for the treatment of pulmonary arterial hypertension. Treprostinil is a synthetic analog of prostacyclin (PGI2).

CAS：81846-19-7
中文别名：曲前列环素;曲前列尼尔;
英文别名：Uniprost;LRX-15;[14C]-Treprostinil;UNII-RUM6K67ESG;Treprostinil;treprostinol;2-((1R,2R,3aS,9aS)-2,3,3a,4,9,9a-hexahydro-2-hydroxy-1-((S)-3-hydroxyoctyl)-1H-cyclopenta[b]naphthalen-5-yloxy)acetic acid;2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid;Tyvaso;15AU81;Remodulin;
分子式：C23H33NaO5
分子量：412.495
精确质量：412.223
Psa：89.82
Logp：2.2485

UNII：RUM6K67ESG

密度：1.158g/cm3
沸点：587.1ºC at 760mmHg
闪点：199.3ºC
折射率：1.553